C. Rutz

发表

The Pseudo Signal Peptide of the Corticotropin-releasing Factor Receptor Type 2A Prevents Receptor Oligomerization*

B. Wiesner, G. Krause, R. Schülein, 2012, The Journal of Biological Chemistry.

Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.

R. Schülein, M. Birnbaumer, W. Rosenthal, 1996, Molecular pharmacology.

Non-HLA antibodies targeting angiotensin II type 1 receptors and endothelin-1 type A receptors impair endothelial repair via a β2-arrestin link to the mTOR pathway.

A. Kusch, D. Dragun, R. Schülein, 2021, Kidney international.

The Sequence after the Signal Peptide of the G Protein-Coupled Endothelin B Receptor Is Required for Efficient Translocon Gating at the Endoplasmic Reticulum Membrane

R. Schülein, G. Kleinau, W. Rosenthal, 2009, Molecular Pharmacology.

The protease‐activated receptor 1 possesses a functional and cleavable signal peptide which is necessary for receptor expression

S. Kubick, R. Schülein, J. Furkert, 2012, FEBS letters.

Evidence of G-protein-coupled receptor and substrate transporter heteromerization at a single molecule level

Catherine L. Worth, B. Wiesner, H. Biebermann, 2017, Cellular and Molecular Life Sciences.

Molecular and conformational features of a transport-relevant domain in the C-terminal tail of the vasopressin V(2) receptor.

G. Krause, R. Hermosilla, R. Schülein, 2000, Molecular pharmacology.

Thyrotropin Receptor: Allosteric Modulators Illuminate Intramolecular Signaling Mechanisms at the Interface of Ecto- and Transmembrane Domain

G. Krause, R. Schülein, J. Furkert, 2019, Molecular Pharmacology.

The signal peptide of the rat corticotropin-releasing factor receptor 1 promotes receptor expression but is not essential for establishing a functional receptor.

R. Hermosilla, R. Schülein, W. Rosenthal, 2005, The Biochemical journal.

The Signal Peptide of the G Protein-coupled Human Endothelin B Receptor Is Necessary for Translocation of the N-terminal Tail across the Endoplasmic Reticulum Membrane*

G. Krause, R. Schülein, W. Rosenthal, 2002, The Journal of Biological Chemistry.

Identification of Key Receptor Residues Discriminating Human Chorionic Gonadotropin (hCG)- and Luteinizing Hormone (LH)-Specific Signaling

G. Krause, M. Simoni, L. Casarini, 2020, International journal of molecular sciences.

Molecular features of the L-type amino acid transporter 2 determine different import and export profiles for thyroid hormones and amino acids

J. Köhrle, G. Krause, R. Schülein, 2017, Molecular and Cellular Endocrinology.

Differences in Signal Activation by LH and hCG are Mediated by the LH/CG Receptor’s Extracellular Hinge Region

B. Wiesner, G. Krause, G. Kleinau, 2015, Front. Endocrinol..

A Single Negatively Charged Residue Affects the Orientation of a Membrane Protein in the Inner Membrane of Escherichia coliOnly When It Is Located Adjacent to a Transmembrane Domain*

R. Schülein, W. Rosenthal, C. Rutz, 1999, The Journal of Biological Chemistry.

A Proteomic Study on the Membrane Protein Fraction of T Cells Confirms High Substrate Selectivity for the ER Translocation Inhibitor Cyclotriazadisulfonamide

E. Hartmann, E. Krause, D. Schols, 2021, Molecular & cellular proteomics : MCP.

The Corticotropin-releasing Factor Receptor Type 2a Contains an N-terminal Pseudo Signal Peptide*

B. Wiesner, K. Schulz, A. Renner, 2006, Journal of Biological Chemistry.

A New Highly Thyrotropin Receptor-Selective Small-Molecule Antagonist with Potential for the Treatment of Graves' Orbitopathy.

G. Krause, R. Schülein, J. Furkert, 2019, Thyroid : official journal of the American Thyroid Association.

N-Terminal Signal Peptides of G Protein-Coupled Receptors: Significance for Receptor Biosynthesis, Trafficking, and Signal Transduction.

R. Schülein, W. Klein, C. Rutz, 2015, Progress in molecular biology and translational science.

Inhibition of Biosynthesis of Human Endothelin B Receptor by the Cyclodepsipeptide Cotransin*

B. Wiesner, R. Schülein, W. Rosenthal, 2011, The Journal of Biological Chemistry.

The Pseudo Signal Peptide of the Corticotropin-releasing Factor Receptor Type 2a Decreases Receptor Expression and Prevents Gi-mediated Inhibition of Adenylyl Cyclase Activity*

B. Wiesner, K. Schulz, R. Schülein, 2010, The Journal of Biological Chemistry.

Defining a Conformational Consensus Motif in Cotransin-Sensitive Signal Sequences: A Proteomic and Site-Directed Mutagenesis Study

J. Protze, G. Krause, E. Krause, 2015, PloS one.

Polarized expression of the vasopressin V2 receptor in Madin-Darby canine kidney cells.

B. Wiesner, R. Schülein, W. Rosenthal, 1999, Kidney international.

The Specific Monomer/Dimer Equilibrium of the Corticotropin-releasing Factor Receptor Type 1 Is Established in the Endoplasmic Reticulum

B. Wiesner, G. Krause, J. Schmoranzer, 2014, The Journal of Biological Chemistry.

Use of a sequential high throughput screening assay to identify novel inhibitors of the eukaryotic SRP-Sec61 targeting/translocation pathway

P. Scheerer, R. Schülein, G. Kleinau, 2018, PloS one.

Mutations that silence constitutive signaling activity in the allosteric ligand-binding site of the thyrotropin receptor

G. Krause, M. Gershengorn, S. Neumann, 2010, Cellular and Molecular Life Sciences.

From Molecular Details of the Interplay between Transmembrane Helices of the Thyrotropin Receptor to General Aspects of Signal Transduction in Family A G-protein-coupled Receptors (GPCRs)*

Catherine L. Worth, Gerd Krause, Annika Kreuchwig, 2011, The Journal of Biological Chemistry.

Signaling‐sensitive amino acids surround the allosteric ligand binding site of the thyrotropin receptor

Gerd Krause, Susanne Neumann, Gunnar Kleinau, 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Membrane Targeting and Determination of Transmembrane Topology of the Human Vasopressin V2 Receptor*

R. Schülein, W. Rosenthal, C. Rutz, 1996, The Journal of Biological Chemistry.

Differences between lutropin‐mediated and choriogonadotropin‐mediated receptor activation

B. Wiesner, G. Krause, R. Schülein, 2014, The FEBS journal.

The Sequence after the Signal Peptide of the G Protein-Coupled Endothelin B Receptor Is Required for Efficient Translocon Gating at the Endoplasmic Reticulum Membrane

R. Schülein, G. Kleinau, W. Rosenthal, 2009, Molecular Pharmacology.